Dermatologic findings associated with semaglutide use: A scoping review

Megan M Tran; Fatima N Mirza; Adrian C Lee; Hayley S Goldbach; Tiffany J Libby; Oliver J Wisco

doi:10.1016/j.jaad.2024.03.021

Dermatologic findings associated with semaglutide use: A scoping review

J Am Acad Dermatol. 2024 Jul;91(1):166-168. doi: 10.1016/j.jaad.2024.03.021. Epub 2024 Mar 29.

Authors

Megan M Tran¹, Fatima N Mirza², Adrian C Lee³, Hayley S Goldbach², Tiffany J Libby², Oliver J Wisco²

Affiliations

¹ Warren Alpert Medical School, Brown University, Providence, Rhode Island.
² Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
³ Brown University, Providence, Rhode Island.

PMID: 38554940
DOI: 10.1016/j.jaad.2024.03.021

No abstract available

Keywords: GLP-1 agonist; adverse events; alopecia; altered skin sensation; cutaneous findings; dermatologic manifestations; diabetes medication; dosage; glucagon-like peptide-1 receptor agonist; obesity medication; scoping review; semaglutide; side effects; skin findings; systematic review; weight loss medication.

Publication types

Review
Letter

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy
Drug Eruptions / etiology
Glucagon-Like Peptides* / adverse effects
Humans
Hypoglycemic Agents* / adverse effects

Substances

semaglutide
Glucagon-Like Peptides
Hypoglycemic Agents